Rua Bioscience (NZSE:RUA) Long-Term Debt: NZ$0.03 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Rua Bioscience Long-Term Debt?

Rua Bioscience NZSE:RUA Long-Term Debt is NZ$0.03 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Rua Bioscience's Long-Term Debt for the quarter that ended in Dec. 2025 was NZ$0.03 Mil.

Rua Bioscience's quarterly Long-Term Debt declined from Dec. 2024 (NZ$0.07 Mil) to Jun. 2025 (NZ$0.00 Mil) but then increased from Jun. 2025 (NZ$0.00 Mil) to Dec. 2025 (NZ$0.03 Mil).

Rua Bioscience  (NZSE:RUA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Rua Bioscience Long-Term Debt Related Terms

Rua Bioscience Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Rua Bioscience's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rua Bioscience Long-Term Debt Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
0.07 0.00 0.00 0.00 0.00

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.12 0.00 0.07 0.00 0.03
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of NZ$0.03 Mil mean?
Rua Bioscience (NZSE:RUA) has a Long-Term Debt of NZ$0.03 Mil as of Dec. 2025.
Is Rua Bioscience's Long-Term Debt too high?
Rua Bioscience's current Long-Term Debt is NZ$0.03 Mil.
How does Rua Bioscience's Long-Term Debt compare to ZTS and UTHR?
Rua Bioscience's Long-Term Debt of NZ$0.03 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Rua Bioscience's current Long-Term Debt is NZ$0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rua Bioscience stock overvalued right now?
Rua Bioscience (NZSE:RUA) has a current Long-Term Debt of NZ$0.03 Mil. The current Long-Term Debt is NZ$0.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Rua Bioscience (NZSE:RUA), the current Long-Term Debt is NZ$0.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rua Bioscience Business Description

Address 704 Te Araroa Road, RD3, Ruatoria, NZL, 4083
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.